We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ORDS:QSEOoredoo Q.P.S.C Analysis

Data as of 2026-07-08 - not real-time

QAR 13.08

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Ooredoo Q.P.S.C. is trading at QAR 13.08, barely above its calculated support of QAR 13.04 and below both the 20‑day (13.44) and 50‑day (13.49) simple moving averages, indicating short‑term pressure. The RSI of 37 and a bearish MACD histogram reinforce a modest downtrend, while the 30‑day volatility of ~19% suggests price swings are still pronounced. On the valuation side, the stock’s trailing P/E of 10.7 is well below the telecom industry average of 16.1, and the DCF‑derived fair value (≈13.14) is essentially in line with the current price, implying limited immediate upside but a clear valuation discount relative to peers.
Fundamentally, Ooredoo delivers solid profitability with a 5.4% revenue growth, 43% gross margin, and a 14.5% ROE, backed by strong operating cash flow (≈9.3 B QAR) and free cash flow (≈2.7 B QAR). The dividend yield of 5.68% and a payout ratio of 61% appear sustainable given the cash generation, while the company’s low beta (≈0.25) points to limited market‑wide risk. Although the balance sheet shows higher debt than cash, the debt‑to‑equity of ~50% remains manageable for a telecom operator. Overall, the stock combines an attractive dividend, defensive fundamentals, and a modest valuation gap, supporting a positive outlook across medium to long horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering near technical support
  • Bearish MACD and modest RSI
  • High dividend yield offering income while awaiting catalyst

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Valuation discount relative to industry P/E
  • Sustainable dividend with strong cash flow
  • Stable earnings and modest revenue growth

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Low beta indicating defensive profile
  • Consistent profitability and ROE above 10%
  • Attractive dividend yield supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth5.40%
Profit Margin15.63%
P/E Ratio10.7
ROE14.56%
ROA5.77%
Debt/Equity49.69
P/B Ratio1.5
Op. Cash FlowQAR9.3B
Free Cash FlowQAR2.7B
Industry P/E16.1

Technical Analysis

TrendNeutral
RSI37.3
SupportQAR 13.04
ResistanceQAR 14.01
MA 20QAR 13.44
MA 50QAR 13.49
MA 200QAR 13.36
MACDBearish
VolumeDecreasing
Fear & Greed Index88.36

Valuation

Fair ValueQAR 13.14
Target PriceQAR 17.04
Upside/Downside30.30%
GradeUndervalued
TypeBlend
Dividend Yield5.68%

Risk Assessment

Beta0.25
Volatility19.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.